ABERNETHY MATT - Insider Non-Derivative Transactions at NEUROCRINE BIOSCIENCES INC (NBIX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 13, 2024, ABERNETHY MATT's relationship to NEUROCRINE BIOSCIENCES INC (NBIX) is Officer (Chief Financial Officer), and currently has 45,628 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other NBIX insiders.
Data Source: SEC.
ABERNETHY MATT - Insider Non-Derivative Transactions of NBIX Common Stock
ABERNETHY MATT - Insider Non-Derivative Transactions at NBIX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 14, 2024 | Sell -- (Common Stock) | 14100 | 150.38 | 31528 |
| Aug 14, 2024 | M -- (Common Stock) | 14100 | 73.6 | 45628 |
| Jul 17, 2024 | Sell -- (Common Stock) | 900 | 150.04 | 31528 |
| Jul 17, 2024 | M -- (Common Stock) | 900 | 73.6 | 32428 |
| May 16, 2024 | Sell -- (Common Stock) | 15000 | 140.24 | 31528 |
| May 16, 2024 | M -- (Common Stock) | 15000 | 73.6 | 46528 |
| May 15, 2024 | Sell -- (Common Stock) | 15000 | 135.66 | 31528 |
| May 15, 2024 | M -- (Common Stock) | 15000 | 73.6 | 46528 |
| Feb 14, 2024 | Sell -- (Common Stock) | 1352 | 132.85 | 31528 |
| Feb 9, 2024 | Sell -- (Common Stock) | 980 | 134.21 | 30314 |
| Feb 7, 2024 | Sell -- (Common Stock) | 1280 | 142.19 | 29434 |
| Feb 1, 2024 | Sell -- (Common Stock) | 1283 | 140.72 | 28284 |
| Aug 22, 2023 | Sell -- (Common Stock) | 2132 | 107.39 | 27131 |
| Feb 9, 2023 | Sell -- (Common Stock) | 980 | 104.19 | 25213 |
| Feb 8, 2023 | Sell -- (Common Stock) | 2030 | 102.33 | 24333 |
| Feb 8, 2023 | Sell -- (Common Stock) | 11491 | 102.4 | 24333 |
| Feb 8, 2023 | Sell -- (Common Stock) | 12807 | 102.42 | 35824 |
| Feb 7, 2023 | Sell -- (Common Stock) | 1280 | 105.67 | 22507 |
| Feb 1, 2023 | Sell -- (Common Stock) | 1283 | 109.98 | 21357 |